Memokath has been presented at the annual congress of the Chinese Urological Association in October 2023 by Pnn Medical staff in collaboration with our partner in China, Cheng Lai.
It was a successful congress and Memokath is now one of the leading urological stents in China and the rest of Asia.
Thank you to our customers and partner for making it happen. We look forward to more joint initiatives in 2023 and 2024. Memokath is expected to become the preferred solution in China, as it is in Japan.
